Clinical Trials Browser

Phase 1/2 × Melanoma × Imiquimod × Clear all

NCT01191034 2019-03-12

Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma

Phase 1/2 Terminated

Melanoma